US2010069645A1PendingUtilityA1
2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid and methyl ester
Est. expiryAug 25, 2024(expired)· nominal 20-yr term from priority
A61P 43/00A61P 31/18A61P 31/00C07D 401/12C07D 249/12C07D 401/04C07D 405/12C07D 249/14A61K 31/4196
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A series of S-triazolyl α-mercaptoacetanilides having general structure (I) are provided, where Q is CO 2 H, CONR 2 , SO 3 H, or SO 2 NR 2 . The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections.
Claims
exact text as granted — not AI-modified1 - 54 . (canceled)
55 . A compound having the structure:
56 . A compound having the structure:Join the waitlist — get patent alerts
Track US2010069645A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.